Madrigal Pharmaceuticals Enters $2 Billion GLP-1 Licensing Deal
Deal News | Jul 30, 2025 | Ropes & Gray
Madrigal Pharmaceuticals has entered into a significant global license agreement with CSPC Pharmaceutical Group for SYH2086, a preclinical oral small molecule GLP-1 receptor agonist. Announced on July 30, the deal was facilitated by Ropes & Gray, who provided legal counsel to Madrigal Pharmaceuticals. The agreement involves an upfront payment of $120 million from Madrigal to CSPC, with potential milestone payments that could bring the total value of the deal to $2 billion. Additionally, there will be royalties on net sales. The advisory team from Ropes & Gray was spearheaded by key legal professionals with expertise in life sciences, tax, and litigation.
Sectors
- Pharmaceuticals
- Legal Services
Geography
- Global – The licensing agreement between Madrigal Pharmaceuticals and CSPC Pharmaceutical Group represents a global deal, as stated in the article.
Industry
- Pharmaceuticals – The article primarily deals with a transaction in the pharmaceutical industry involving a drug licensing agreement.
- Legal Services – Ropes & Gray, a law firm, played a critical role in advising the licensing agreement, highlighting the relevance of legal services in such transactions.
Financials
- $120 million – Upfront payment from Madrigal Pharmaceuticals to CSPC Pharmaceutical Group.
- $2 billion – Potential total milestone payments and royalties on net sales from Madrigal Pharmaceuticals to CSPC Pharmaceutical Group under the license agreement.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Madrigal Pharmaceuticals | Client | Company | A biopharmaceutical company involved in the global licensing agreement for the drug SYH2086. |
| CSPC Pharmaceutical Group | Licensor | Company | A pharmaceutical group offering the license for SYH2086, a preclinical oral small molecule GLP-1 receptor agonist. |
| Ropes & Gray | Legal Advisor | Company | Ropes & Gray is the legal advisor to Madrigal Pharmaceuticals in this licensing deal. |
| Hannah England | Lead Partner | Person | Life sciences licensing partner at Ropes & Gray leading the advisory team for the Madrigal Pharmaceuticals agreement. |
| Ryan Kramer | Associate | Person | Life sciences licensing associate involved in the advisory team for Madrigal Pharmaceuticals. |
| David Saltzman | Tax Partner | Person | Tax partner at Ropes & Gray involved in the transaction. |
| Lisa Kaltenbrunner | Litigation & Enforcement Partner | Person | Litigation & enforcement partner at Ropes & Gray involved in the transaction. |